The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/16466
StudyName: Eligibility Carcinoma, Renal Cell NCT00523640
Date of export from the portal: 02.07.2020
Date of Upload / last change: 17.07.2016
License: Creative Commons BY 4.0

----

Description: 
A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00523640
